Search Results 1511-1520 of 17799 for Substance+dependence
Reducing Cancer Drug Cost: 3-Year Analysis of Automated Dose Rounding in ... KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
The purpose of this study is to test the safety and tolerability of a drug called BAY 1895344 in combination with irinotecan or topotecan at different doses.
... drug (AAD) 3. Patient is ≥ 18 years of age 4. Planned de novo pulmonary vein isolation procedure using commercially available Sphere-9™ Catheter and Affera ...
Deep brain stimulation in drug addiction treatment: Research progress and perspective. Frontiers in Psychiatry. 2022; doi:10.3389/fpsyt.2022.858638. Medical ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
- Investigational Drug Sub-study A: Brigatinib. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
... drug targeting T-cell costimulation; Treatment with systemic immunostimulatory agents (including but not limited to interleukin-2) within 4 weeks or five ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.